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Research
first aid bodies, including the International
Life Saving Federation,3 recommend treat-
ment by topical application of ice packs.
There is little scientific evidence to support
this,2 and the only study to investigate ice
packs was observational with no objective
measure of pain, or control or comparator
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Objective:  To investigate the effectiveness of hot water immersion for the treatment of 
Physalia sp. (bluebottle or Portuguese Man-of-War) stings.
Design:  Open-label, randomised comparison trial. Primary analysis was by intention to 
treat, with secondary analysis of nematocyst-confirmed stings. One halfway interim 
analysis was planned.
Setting:  Surf lifesaving first aid facilities at two beaches in eastern Australia from 30 
ber 2003 to 5 March 2005.
pants:  96 subjects presenting after swimming in the ocean for treatment of an 
nt sting by a bluebottle.
ntions:  Hot water immersion (45°C) of the affected part versus ice pack 
tion.
utcome measures:  The primary outcome was a clinically important reduction in 
 measured by the visual analogue scale (VAS). Secondary outcomes were the 
development of regional or radiating pain, frequency of systemic symptoms, and 
proportion with pruritus or rash on follow-up.
Results:  49 patients received hot water immersion and 47 received ice packs. The two 
groups had similar baseline features, except patients treated with hot water had more 
severe initial pain (VAS [mean ± SD]: 54 ±22 mm versus 42 ±22 mm). After 10 minutes, 53% 
of the hot water group reported less pain versus 32% treated with ice (21%; 95% CI, 1%–
39%; P = 0.039). After 20 minutes, 87% of the hot water group reported less pain versus 
33% treated with ice (54%; 95% CI, 35%–69%; P = 0.002). The trial was stopped after the 
halfway interim analysis because hot water immersion was shown to be effective (P =
0.002). Hot water was more effective at 20 minutes in nematocyst-confirmed stings (95% 
versus 29%; P = 0.002). Radiating pain occurred less with hot water (10% versus 30%; P =
0.039). Systemic effects were uncommon in both groups.
Conclusions:  Immersion in water at 45°C for 20 minutes is an effective and practical 
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treatment for pain from bluebottle stings.
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T usands of bluebottle (Physalia sp.)ngs occur each year in Australia.1ngs cause immediate, intense pain
lly resolves within an hour and is
associated with a characteristic linear ery-
thematous eruption (Box 1).2 The first aid
management of bluebottle stings is a daily
problem for surf lifesavers. Currently, most
treatment.4
Many marine venoms are heat-labile in
vitro.5-8 It is feasible that heat penetrates the
human dermis to the estimated depth that
nematocysts inject toxins (100–1000 μm),1
and recent clinical research suggests heat
may be effective for treating jellyfish
stings.9,10 However, previous studies of heat
therapy were small10,11 or not ran-
domised,11,12 and only one was published in
full.12 A randomised controlled trial showed
that, compared with ice packs, hot showers
significantly reduced pain and treatment
duration for bluebottle stings.10
If heat is to be used, it needs to be applied
continuously. Furthermore, it has to be eas-
ily and rapidly administered at the beach.
The risk of burns is temperature- and time-
dependent, and superficial burns have been
reported only with skin exposures longer
than 1 hour and with temperatures over
46° C.13 Therefore, we chose immersion of
the sting site in 45°C water for 20 minutes
as an appropriate safe treatment for blue-
bottle stings, and compared this with the
currently recommended treatment using ice
packs.
METHODS
Study design
The study was a randomised open-label
comparison of hot water immersion (45°C)
versus ice packs for treating pain from blue-
bottle stings. Patients were randomly
assigned either hot water immersion or
application of ice packs.
The Hunter Area Research Ethics Com-
mittee and the Human Research Ethics
Committee of the University of Newcastle
approved the study.
Study patients
From 30 December 2003 to 5 March 2005,
subjects were recruited from two surf life-
saving first aid facilities in Newcastle. Writ-
ten informed consent was obtained from the
patients or, if under 16 years of age, their
parent or guardian.
Subjects presenting for treatment of an
apparent bluebottle sting were eligible for the
study. They were included if they had
immediate localised pain and observed a
bluebottle, or they had the characteristic lin-
ear wheal and flare reaction. Children under
the age of 8 years were ineligible as the visual
analogue scale (VAS: the tool we used for
assessing the primary outcome measure) is
not validated for this age group.15 Patients
were also excluded if they had a sting to the
eye or appeared sufficiently unwell that
ambulance attention was required.
Randomisation
Subjects were randomly allocated in a 1:1
ratio to a treatment group after agreeing to
stay for 20 minutes and consenting to the
study. They were randomised to receive
either hot water immersion or ice packs,
using sequentially numbered sealed enve-
lopes containing the study documents
stamped with either “warm” or “cold” to
indicate treatment. Randomisation was inMJA • Volume 184 Number 7 • 3 April 2006 329
RESEARCHblocks of six (AABABB, BABAAB, etc.)
divided into two separate groups for the two
beaches using a computer-generated
sequence of random numbers. Blinding of
the patients or investigators was not possible
due to the types of treatments. However, to
ensure allocation concealment, the enve-
lopes were not opened until after the patient
consented.
Study procedure
Patients were enrolled by the investigators
or paid study assistants, the latter receiving
training before enrolling patients. Personnel
were present at study sites for most days
when conditions were appropriate for blue-
bottle stings. Following baseline assessment,
the allocated treatment was undertaken.
After 20 minutes, subjects were offered
crossover to the opposite treatment.
Hot water treatment consisted of immer-
sion of the affected body part in water at
45° C for 20 minutes. Water was delivered
by hose to truncal stings or into a large
bucket for limb immersion. Accurate water
temperature was ensured by using thermo-
static mixing valves (Aquablend 2000,
Enware Australia Pty Ltd, Sydney, NSW),
which both surf lifesaving clubs allowed to
be connected to the hot water system. Water
temperature was checked daily by spirit
thermometer to ensure accurate calibration
(accuracy ±0.1°C).
Ice pack treatment consisted of placing
disposable ice packs (Glad, Sydney, NSW)
from a portable freezer at −4° C onto the
affected area for as long as the patient could
tolerate during the 20-minute period.
Collection of data
Baseline data included sex, age and sting
site. The patient was also asked to score
their initial pain on a VAS. Patients were
instructed to make a single vertical mark on
a horizontal, ungraduated 100 mm line
labelled “No pain” at the left end and “Worst
pain possible” at the right end. Subsequent
VAS scores were recorded 10 and 20 min-
utes after commencement of treatment.
Investigators also recorded the presence of
radiating pain, generalised pain, nausea or
vomiting, and respiratory symptoms.
Adhesive tape (3M, St Paul, Minn, USA)
was placed over the sting site and then stuck
to a numbered microscope slide.16 Nemato-
cysts were identified microscopically by one
author (J E S) using cnidome libraries.
Subjects were telephoned about 24 hours
after presentation and asked about systemic
symptoms, persistent pain, itchiness or rash.
If symptoms persisted, subjects were fol-
lowed up until the symptoms resolved.
Analysis
The primary outcome for the study was a
clinically important reduction in pain 10 and
20 minutes after treatment. A clinically impor-
tant reduction in pain was taken to be the
reduction in the VAS score equivalent to the
patient description of “a lot better” (Box 2).17
Secondary outcomes were the develop-
ment of regional or radiating pain, general-
ised pain, frequency of systemic symptoms
(nausea, vomiting, respiratory symptoms),
crossover to the alternative treatment, and
proportion with pruritus or rash on follow-
up. For secondary analyses, patients were
only included if data for the outcome were
available. All primary and secondary out-
comes were decided a priori and registered
with the ethics committee.
For all outcomes, a P value of less than
0.05 was considered to indicate statistical
significance. Proportions were compared
using Fisher’s exact test.
The sample size was based on the
assumption that a reduction in pain would
be reported by 30% of patients after ice
treatment and 48% after heat treatment.10
Our study was powered at 80% to detect a
20% absolute increase in patients with clini-
cally important pain reduction after hot
water immersion compared with ice packs,
at an α level of 0.05. The number of patients
required was 190.
2 Definition of clinically important 
reduction in pain17
A clinically important reduction in pain was taken 
to be the reduction in the visual analogue scale 
(VAS) score equivalent to the patient description of 
“a lot better”, as defined by Bird and Dickson.17 
This change in millimeters on the VAS is 
dependent on the baseline starting point and is 
16 mm for an initial VAS in the range 0–33 mm, 
33 mm for 34–66 mm and 48 mm for 67–100 mm. 
The figure shows a VAS divided into three and the 
associated reduction in VAS required to indicate a 
clinically important reduction in pain. ◆
Worst pain
possible
No
pain
0                     33   34                66   67                 100 
“A lot better” > 48 mm 
“A lot better” > 33 mm 
“A lot better” > 16 mm 
1 Linear erythematous eruption 
following a bluebottle sting
3 Recruitment and treatment of patients presenting with an apparent 
bluebottle sting at two beaches in Newcastle between 30 December 2003 
and 5 March 2005
369 Physalia stings
96 enrolled in study
273 excluded or declined:
 • Not referred by life-savers:
  o Very minor sting
  o Investigators busy
 • Age < 8 years
 • Eye sting
 • Severe effects  ambulance
 • Did not want to wait 20 minutes
 • Would not consent49 assigned hot water
49 VAS at 10 minutes
45 VAS at 20 minutes
47 assigned ice packs
47 VAS at 10 minutes
43 VAS at 20 minutes
4 patients left4 patients left330 MJA • Volume 184 Number 7 • 3 April 2006
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because of the possibility that the treatment
effect of hot water immersion would be
greater, using a stopping rule that required a
two-sided P value of 0.01 for the primary
outcome. The main analysis was by inten-
tion to treat. A second planned analysis
included only nematocyst-confirmed
Physalia stings.
To address the baseline imbalance in pain
severity between the two groups, we simu-
lated subgroups of patients matched for
baseline VAS scores (VAS of hot water and
ice treatment patients within 2 mm or less of
each other) and re-examined them for the
primary outcome. Details of the simulations
using Mathematica 5.1.1 are available from
the authors.
All statistical analyses were done using
StatXact version 4.0 (Cytel Software Corpora-
tion, Cambridge, Mass, USA), StatsDirect ver-
sion 2.4.4 (StatsDirect Ltd, Cheshire, UK)
and Mathematica version 5.1.1 (Wolfram
Research Inc, Champaign, Ill, USA).
RESULTS
Ninety-six patients were enrolled, of a possible
369 people in the study (Box 3). Forty-nine
were treated with hot water and 47 with ice
packs. All randomly assigned patients
underwent their designated treatment and
completed a VAS at 10 minutes, but eight
patients did not remain for the 20 minutes
(Box 3). The two groups had similar base-
line features, except patients treated with
hot water had more severe initial pain than
those treated with ice packs (Box 4).
Samples collected using adhesive tape
were obtained from 93 patients. Physalia
nematocysts were identified in 42 patients
(22 treated with hot water and 20 with ice
packs), and Pelagia noctiluca (Mauve stinger)
in one patient.
The trial was stopped at the halfway
interim analysis because hot water immer-
sion was shown to be effective at 20 minutes
(P = 0.002).
Primary outcome
After 10 minutes, 26 (53%) of the hot water
group had clinically reduced pain versus 15
(32%) treated with ice packs (Box 5). After
20 minutes, 39 (87%) of the hot water
group had clinically reduced pain versus 14
(33%) treated with ice packs. Box 6 shows
all patients divided into their treatment
groups and whether they had a clinically
important pain reduction. All patients
treated with hot water who had less pain at
10 minutes remained better at 20 minutes,
but three patients treated with ice packs
who had less pain at 10 minutes reported
worsening pain at 20 minutes.
Box 5 also shows results for patients with
nematocyst-confirmed stings, and for
patients for whom the initial VAS was
matched to within 2 mm.
Secondary outcomes
Radiating pain occurred less with hot water
(difference, −20%; 95% CI, −39% to −0.003%;
P = 0.039), and systemic effects were
uncommon in both groups (Box 7). Respira-
tory symptoms were reported in one patient,
who had chest tightness that resolved
spontaneously.
No patient suffered a burn from hot water
immersion, but transient erythema was
common. There were no adverse effects
from the application of ice packs, but
patients found it difficult to keep the ice
applied continuously.
No patient treated with hot water
reported recurrence of pain or re-presented.
Two patients treated with ice packs who left
after 10 minutes re-presented.
The proportion of patients with itch, red-
ness or rash at 24 hours was similar in both
groups (Box 7). Two patients (one in each
group) developed bullae within 48 hours of
the sting; these took 1 to 2 weeks to resolve.
DISCUSSION
We found that hot water immersion was
highly effective compared with ice packs in
the treatment of pain caused by bluebottle
stings. The treatment effect with hot water
immersion improved between 10 and 20
minutes (53% to 87% with clinically impor-
tant pain reduction), whereas there was no
further improvement (from 32%) for
patients treated with ice packs. This was
similar to a previous study, in which 30%
responded to ice packs, and suggests that
the response to ice packs may have been a
placebo effect.18,19
The measurement of pain is problematic
because it is subjective and is influenced by
numerous factors. However, pain is the most
important and distressing effect of bluebot-
tle stings, so it was essential that we estab-
4 Baseline characteristics of the two 
treatment groups
Hot water 
immersion 
(n = 49)
Ice 
packs 
(n = 47)
Mean (SD) age* 
(years)
19 (10) 18 (10)
Sex (male) 55% 57%
Location of sting
Proximal limb 47% 47%
Distal limb 16% 17%
Trunk 12% 9%
Head and neck 6% 9%
Multiple sites 14% 17%
Unknown 4% 2%
Mean (SD) initial VAS 
(mm)
54 (22) 42 (22)
* Age was not known for two patients receiving hot 
water and one receiving ice packs. ◆
5 Comparison of the treatment groups at 10 and 20 minutes 
Hot water Ice packs
Difference (95%CI)n/N % n/N % P
Intention to treat
10 minutes 26/49 53% 15/47 32% 21% (1% to 39%) 0.039
20 minutes 39/45 87% 14/43 33% 54% (35% to 69%) 0.002
Nematocyst confirmed 
10 minutes 11/22 50% 5/20 25% 25% (−5% to 57%) 0.106
20 minutes 20/21 95% 5/17 29% 66% (36% to 88%) 0.002
Matched initial VAS 
score
10 minutes 15/36 42% 12/36 33% 9% (−14% to 30%) 0.4785
20 minutes 26/36 72% 11/36 31% 42% (19% to 60%) 0.0005
Data are reported as number with clinically important pain reduction/total number in the analysis for that 
treatment group. VAS = visual analogue scale. ◆MJA • Volume 184 Number 7 • 3 April 2006 331
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has become a standard tool for the measure-
ment of pain in research, and has been
validated in numerous settings.17 Recently, it
has been used in studies of painful enven-
oming, including jellyfish stings and widow
spider bites.9,10,20 Some controversy exists
over what constitutes a clinically important
reduction in pain and whether this amount
varies depending on baseline score. Studies
measuring acute pain have compared the
numerical change in the VAS with the
patient ’s  description of a “lot less
pain”.17,21,22 In this study, we chose to
define a clinically important reduction in
pain as a “lot less” according to the criteria of
Bird and Dickson,17 where a clinically
important reduction in pain varied with
initial VAS (Box 2).
There was an inevitable selection bias in
our study in favour of patients with more
severe stings. Only a small proportion of the
total number of swimmers stung on a given
day present for treatment, and a proportion
of these declined to enter the study, most
commonly because of the requirement to
stay for 20 minutes. It is likely that a
population with more severe stings was
selected.
Another limitation was the possible pres-
ence of allocation bias, suggested by the
baseline imbalance in pain severity. Patients
gave consent to participate before being
randomly allocated a treatment and were
accepted in order of presentation. However,
bluebottles occur in clusters, so there were
sometimes large numbers of potential
recruits with stings of varying severity. We
suspect in some cases when two or three
patients were simultaneously recruited
(often one parent consenting for multiple
children), the research assistants may have
allocated hot water treatment to the more
severe stings once the envelopes were open.
However, this was likely to be rare, and a
post-hoc analysis using simulations of
matched treatment subgroups still showed a
highly significant outcome at 20 minutes
(Box 6).
Our study demonstrated a greater
improvement with hot water treatment than
Bowra et al reported (87% versus 48%).10
This is probably because the immersion
technique maintained a constant 45°C tem-
perature directly in contact with the sting
site. Showers (as used by Bowra et al10)
deliver variable water temperature depend-
ing on height, nozzle design and settings on
the water mixer. The immersion technique
was also safer because it prevented exposure
to temperatures over 46° C.13 The use of
thermostatic mixing valves meant it was
possible to supply water at exactly 45° C. In
our experience, the technique was cost-
effective and practical at beach first aid
stations once thermostatic mixing valves
had been installed.
It might be argued that the hot water
immersion may be a symptomatic treatment
for jellyfish stings, rather than providing
definitive treatment by inactivating venom.
A similar controversy exists for venomous
fish stings, because hot water immersion has
been recommended for decades on the basis
that fish venoms are heat labile.5 However, it
is a common observation that the pain of
venomous fish stings is only alleviated while
the injured part is immersed, suggesting that
venom is not inactivated and treatment is
only symptomatic.2 In jellyfish stings, the
venom remains close to the surface, unlike
penetrating fish injuries where venom is
injected deeper.1,2 We demonstrated a time-
dependent effect of hot water immersion,
with a barely significant effect at 10 minutes
and a highly significant effect at 20 minutes.
In addition, pain did not recur. This leads us
to suggest that the mechanism of reducing
pain by heat treatment is inactivation of
venom.
We recommend that treatment guidelines
for bluebottle stings be modified to recom-
mend hot water immersion, and that further
studies be undertaken for other jellyfish
stings and in other settings, such as emer-
gency departments.
6 Change (reduction) in visual analogue scale (VAS) at 20 minutes (VAS20 – VAS0) 
compared with baseline (VAS0) for all patients
Patients receiving hot water and patients receiving ice packs are divided into three groups based on their 
initial VAS (see Box 2). The black lines divide patients who had clinically important reduction in pain (above the 
line) from those who did not (below the line). ◆
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7 Secondary outcomes at initial treatment and at 24-hour follow-up
Hot water immersion Ice packs
n/N % (95% CI) n/N % (95% CI)
Clinical effects
Pain radiating 5/49 10% (4%–22%) 14/47 30% (17%–45%)
Generalised pain 1/49 2% (0–11%) 3/47 6% (1%–18%)
Nausea/vomiting 2/49 4% (1%–14%) 5/47 11% (4%–23%)
Crossed over to other treatment* 5/45 11% (4%–24%) 11/43 26% (14%–41%)
Follow-up
Itchiness (24 hours or later) 18/42 43% (28%–59%) 17/41 41% (26%–58%)
Red mark or minor rash 18/42 43% (28%–59%) 17/41 41% (26%–58%)
Raised and red/wheal reaction 8/42 19% (10%–33%) 11/41 27% (14%–43%)
Bullous reaction 1/42 3% (0–13%) 1/41 2% (0–13%)
* Four patients in each group did not remain for 20 minutes (after which crossover was offered). Thirteen 
patients could not be contacted for follow-up. ◆332 MJA • Volume 184 Number 7 • 3 April 2006
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